Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism
FDA has received seven reports of patients experiencing PE during, or soon after, a treatment.
FDA has received seven reports of patients experiencing PE during, or soon after, a treatment.
80.211.154.110